Poland· PL-100517278
Lenzetto
A estradiol product containing estradiolum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Estradiol is registered in 13 of 19 countries.
Countries holding a registration under ATC G03CA03 (estradiol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Estradiol · ATC G03CA03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of estradiol costs, country by country.
Normalised to the WHO defined daily dose (0.3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Estradiol · price per daily dose (0.3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.11
The record
At a glance
URPL (Poland)- Active substance
- Estradiolum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G03CA03
- ATC class
- Estradiol
- Defined daily dose
- 0.3 mg, N
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991571320
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
328 interactions on record for estradiol.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Estradiol · interactions on record
328 records
- 7 severe
- 177 moderate
- 3 minor
- 131 info
Most severe, free to view
- Tranexamic acidB02AA02severe
- HeminB06AB01severe
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
10 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G03CA03
Estradiol, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7efd1089-9ee8-4e53-934e-6ec26954fc0f GET /v1/drugs/7efd1089-9ee8-4e53-934e-6ec26954fc0f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol przezskórny, roztwór",
"source": "urpl",
"strength": "1,53 mg/dawkę",
"packaging": "05909991571320 ¦ Rp ¦ 161557\n1 butelka 6,5 ml",
"substance": "Estradiolum 1.53 mg/dawkę",
"common_name": "Estradiolum",
"pl_product_id": "100517278",
"pozwolenie_nr": "149/25",
"auth_procedure": "IR",
"authorisation_validity": "2030-04-24"
}See everything about estradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.